|
1
|
Nüsslein-Volhard C and Wieschaus E:
Mutations affecting segment number and polarity in Drosophila.
Nature. 287:795–801. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen JK, Taipale J, Cooper MK and Beachy
PA: Inhibition of Hedgehog signaling by direct binding of
cyclopamine to Smoothened. Genes Dev. 16:2743–2748. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duman-Scheel M, Weng L, Xin S and Du W:
Hedgehog regulates cell growth and proliferation by inducing Cyclin
D and Cyclin E. Nature. 417:299–304. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lum L and Beachy PA: The Hedgehog response
network: Sensors, switches, and routers. Science. 304:1755–1759.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taipale J, Chen JK, Cooper MK, Wang B,
Mann RK, Milenkovic L, Scott MP and Beachy PA: Effects of oncogenic
mutations in Smoothened and Patched can be reversed by cyclopamine.
Nature. 406:1005–1009. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasaki H, Nishizaki Y, Hui C, Nakafuku M
and Kondoh H: Regulation of Gli2 and Gli3 activities by an
amino-terminal repression domain: Implication of Gli2 and Gli3 as
primary mediators of Shh signaling. Development. 126:3915–3924.
1999.PubMed/NCBI
|
|
8
|
Alvarez JI, Dodelet-Devillers A, Kebir H,
Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L,
Bernard M, et al: The Hedgehog pathway promotes blood-brain barrier
integrity and CNS immune quiescence. Science. 334:1727–1731. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shin K, Lee J, Guo N, Kim J, Lim A, Qu L,
Mysorekar IU and Beachy PA: Hedgehog/Wnt feedback supports
regenerative proliferation of epithelial stem cells in bladder.
Nature. 472:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Petrova R and Joyner AL: Roles for
Hedgehog signaling in adult organ homeostasis and repair.
Development. 141:3445–3457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bermudez O, Hennen E, Koch I, Lindner M
and Eickelberg O: Gli1 mediates lung cancer cell proliferation and
Sonic Hedgehog-dependent mesenchymal cell activation. PLoS One.
8:e632262013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang L, Walter V, Hayes DN and Onaitis M:
Hedgehog-GLI signaling inhibition suppresses tumor growth in
squamous lung cancer. Clin Cancer Res. 20:1566–1575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You M, Varona-Santos J, Singh S, Robbins
DJ, Savaraj N and Nguyen DM: Targeting of the Hedgehog signal
transduction pathway suppresses survival of malignant pleural
mesothelioma cells in vitro. J Thorac Cardiovasc Surg. 147:508–516.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bosco-Clément G, Zhang F, Chen Z, Zhou HM,
Li H, Mikami I, Hirata T, Yagui-Beltran A, Lui N, Do HT, et al:
Targeting Gli transcription activation by small molecule suppresses
tumor growth. Oncogene. 33:2087–2097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wickström M, Dyberg C, Shimokawa T,
Milosevic J, Baryawno N, Fuskevåg OM, Larsson R, Kogner P,
Zaphiropoulos PG and Johnsen JI: Targeting the hedgehog signal
transduction pathway at the level of GLI inhibits neuroblastoma
cell growth in vitro and in vivo. Int J Cancer. 132:1516–1524.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rieber J, Schmitt J, Warth A, Muley T,
Kappes J, Eichhorn F, Hoffmann H, Heussel CP, Welzel T, Debus J, et
al: Outcome and prognostic factors of multimodal therapy for
pulmonary large-cell neuroendocrine carcinomas. Eur J Med Res.
20:642015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niho S, Kenmotsu H, Sekine I, Ishii G,
Ishikawa Y, Noguchi M, Oshita F, Watanabe S, Nakajima R, Tada H, et
al: Combination chemotherapy with irinotecan and cisplatin for
large-cell neuroendocrine carcinoma of the lung: A multicenter
phase II study. J Thorac Oncol. 8:980–984. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Battafarano RJ, Fernandez FG, Ritter J,
Meyers BF, Guthrie TJ, Cooper JD and Patterson GA: Large cell
neuroendocrine carcinoma: An aggressive form of non-small cell lung
cancer. J Thorac Cardiovasc Surg. 130:166–172. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watkins DN, Berman DM, Burkholder SG, Wang
B, Beachy PA and Baylin SB: Hedgehog signalling within airway
epithelial progenitors and in small-cell lung cancer. Nature.
422:313–317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vestergaard J, Pedersen MW, Pedersen N,
Ensinger C, Tümer Z, Tommerup N, Poulsen HS and Larsen LA: Hedgehog
signaling in small-cell lung cancer: Frequent in vivo but a rare
event in vitro. Lung Cancer. 52:281–290. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carbone DP, Koros AM, Linnoila RI, Jewett
P and Gazdar AF: Neural cell adhesion molecule expression and
messenger RNA splicing patterns in lung cancer cell lines are
correlated with neuroendocrine phenotype and growth morphology.
Cancer Res. 51:6142–6149. 1991.PubMed/NCBI
|
|
22
|
Senden N, Linnoila I, Timmer E, van de
Velde H, Roebroek A, Van de Ven W, Broers J and Ramaekers F:
Neuroendocrine-specific protein (NSP)-reticulons as independent
markers for non-small cell lung cancer with neuroendocrine
differentiation. An in vitro histochemical study. Histochem Cell
Biol. 108:155–165. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koyama N, Zhang J, Huqun, Miyazawa H,
Tanaka T, Su X and Hagiwara K: Identification of IGFBP-6 as an
effector of the tumor suppressor activity of SEMA3B. Oncogene.
27:6581–6589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Odate S, Onishi H, Nakamura K, Kojima M,
Uchiyama A, Kato M and Katano M: Tropomyosin-related kinase B
inhibitor has potential for tumor regression and relapse prevention
in pulmonary large cell neuroendocrine carcinoma. Anticancer Res.
33:3699–3703. 2013.PubMed/NCBI
|
|
25
|
Tatematsu T, Sasaki H, Shimizu S, Okuda K,
Shitara M, Hikosaka Y, Moriyama S, Yano M, Brown J and Fujii Y:
Investigation of neurotrophic tyrosine kinase receptor 1 fusions
and neurotrophic tyrosine kinase receptor family expression in
non-small-cell lung cancer and sensitivity to AZD7451 in vitro. Mol
Clin Oncol. 2:725–730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armas-López L, Zúñiga J, Arrieta O and
Ávila-Moreno F: The Hedgehog-GLI pathway in embryonic development
and cancer: Implications for pulmonary oncology therapy.
Oncotarget. 8:60684–60703. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giroux Leprieur E, Vieira T, Antoine M,
Rozensztajn N, Rabbe N, Ruppert AM, Lavole A, Cadranel J and Wislez
M: Sonic Hedgehog pathway activation is associated with resistance
to platinum-based chemotherapy in advanced non-small-cell lung
carcinoma. Clin Lung Cancer. 17:301–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Byrne EFX, Sircar R, Miller PS, Hedger G,
Luchetti G, Nachtergaele S, Tully MD, Mydock-McGrane L, Covey DF,
Rambo RP, et al: Structural basis of Smoothened regulation by its
extracellular domains. Nature. 535:517–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lauth M, Bergström A, Shimokawa T and
Toftgård R: Inhibition of GLI-mediated transcription and tumor cell
growth by small-molecule antagonists. Proc Natl Acad Sci USA.
104:pp. 8455–8460. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Regl G, Kasper M, Schnidar H, Eichberger
T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C,
Frischauf AM and Aberger F: Activation of the BCL2 promoter in
response to Hedgehog/GLI signal transduction is predominantly
mediated by GLI2. Cancer Res. 64:7724–7731. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bai CB and Joyner AL: Gli1 can rescue the
in vivo function of Gli2. Development. 128:5161–5172.
2001.PubMed/NCBI
|
|
32
|
Roessler E, Du YZ, Mullor JL, Casas E,
Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A
and Muenke M: Loss-of-function mutations in the human GLI2 gene are
associated with pituitary anomalies and holoprosencephaly-like
features. Proc Natl Acad Sci USA. 100:pp. 13424–13429. 2003;
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Regl G, Neill GW, Eichberger T, Kasper M,
Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM and Aberger
F: Human GLI2 and GLI1 are part of a positive feedback mechanism in
Basal Cell Carcinoma. Oncogene. 21:5529–5539. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dahmane N, Lee J, Robins P, Heller P and
Ruiz i Altaba A: Activation of the transcription factor Gli1 and
the Sonic hedgehog signalling pathway in skin tumours. Nature.
389:876–881. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bonifas JM, Pennypacker S, Chuang PT,
McMahon AP, Williams M, Rosenthal A, De Sauvage FJ and Epstein EH
Jr: Activation of expression of hedgehog target genes in basal cell
carcinomas. J Invest Dermatol. 116:739–742. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li H, Lui N, Cheng T, Tseng HH, Yue D,
Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, et al: Gli as a
novel therapeutic target in malignant pleural mesothelioma. PLoS
One. 8:e573462013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Narita S, So A, Ettinger S, Hayashi N,
Muramaki M, Fazli L, Kim Y and Gleave ME: GLI2 knockdown using an
antisense oligonucleotide induces apoptosis and chemosensitizes
cells to paclitaxel in androgen-independent prostate cancer. Clin
Cancer Res. 14:5769–5777. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Long B, Wang LX, Zheng FM, Lai SP, Xu DR,
Hu Y, Lin DJ, Zhang XZ, Dong L, Long ZJ, et al: Targeting GLI1
suppresses cell growth and enhances chemosensitivity in
CD34+ enriched acute myeloid leukemia progenitor cells.
Cell Physiol Biochem. 38:1288–1302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sims-Mourtada J, Izzo JG, Ajani J and Chao
KS: Sonic Hedgehog promotes multiple drug resistance by regulation
of drug transport. Oncogene. 26:5674–5679. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Amable L, Fain J, Gavin E and Reed E: Gli1
contributes to cellular resistance to cisplatin through altered
cellular accumulation of the drug. Oncol Rep. 32:469–474. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shi T, Mazumdar T, Devecchio J, Duan ZH,
Agyeman A, Aziz M and Houghton JA: cDNA microarray gene expression
profiling of hedgehog signaling pathway inhibition in human colon
cancer cells. PLoS One. 5:52010. View Article : Google Scholar
|
|
42
|
Mazumdar T, DeVecchio J, Agyeman A, Shi T
and Houghton JA: The GLI genes as the molecular switch in
disrupting Hedgehog signaling in colon cancer. Oncotarget.
2:638–645. 2011. View Article : Google Scholar : PubMed/NCBI
|
